Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
This report contains market size and forecasts of ED Treatment in global, including the following market information:
Global ED Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global ED Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five ED Treatment companies in 2021 (%)
The global ED Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sildenafil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ED Treatment include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma and Seoul Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ED Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ED Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ED Treatment Market Segment Percentages, by Type, 2021 (%)
Sildenafil
Tadalafil
Others
Global ED Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ED Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Other
Global ED Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ED Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ED Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies ED Treatment revenues share in global market, 2021 (%)
Key companies ED Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies ED Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.